NKX6-2

Chr 10AR

NK6 homeobox 2

Also known as: GTX, NKX6.2, NKX6B, SPAX8

Enables sequence-specific double-stranded DNA binding activity. Predicted to be involved in cell differentiation; regulation of DNA-templated transcription; and regulation of myelination. Predicted to act upstream of or within several processes, including central nervous system myelination; pancreatic A cell differentiation; and regulation of oligodendrocyte differentiation. Predicted to be located in chromatin. Predicted to be active in nucleus. Implicated in spastic ataxia 8. [provided by Alliance of Genome Resources, Apr 2025]

GeneReviewsOMIMResearchGenerating clinical summary…
LOFmechanismARLOEUF 1.311 OMIM phenotype
Clinical SummaryNKX6-2
Population Constraint (gnomAD)
Low constraint (pLI 0.03) — loss-of-function variants are relatively tolerated in the population.
📋
ClinVar Variants
23 unique Pathogenic / Likely Pathogenic· 101 VUS of 188 total submissions
📖
GeneReview available — NKX6-2
Authoritative clinical overview · Recommended first read
Open GeneReview ↗

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint?
1.31LOEUF
pLI 0.029
Z-score 1.09
OE 0.51 (0.231.31)
Tolerant

Highly tolerant — LoF variants common in population

Missense Constraint?
-0.14Z-score
OE missense 1.04 (0.891.21)
120 obs / 115.8 exp
Tolerant

Tolerant to missense variation

Observed / Expected Ratios?
LoF OE?0.51 (0.231.31)
00.351.4
Missense OE?1.04 (0.891.21)
00.61.4
Synonymous OE?1.03
01.21.6
LoF obs/exp: 3 / 5.8Missense obs/exp: 120 / 115.8Syn Z: -0.20
Curated Mechanism (G2P)Gene2Phenotype (DDG2P) ↗
strongNKX6-2-related progressive spastic ataxia and hypomyelinationLOFAR

This gene — mechanism propensity

Predictions shown for reference only — model trained on dominant genes, not applicable to AR conditions.

DN
0.74top 25%
GOF
0.4085th %ile
LOF
0.58top 25%

The Badonyi & Marsh prediction model was trained exclusively on dominant disease genes. Predictions are not reliable for genes with autosomal recessive inheritance and are shown at reduced opacity for reference only.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312. Mechanism ranking also informed by gnomAD constraint, ClinVar, and ClinGen data.

ClinVar Variant Classifications

188 submitted variants in ClinVar

Classification Summary

Pathogenic11
Likely Pathogenic12
VUS101
Likely Benign56
Benign6
Conflicting1
11
Pathogenic
12
Likely Pathogenic
101
VUS
56
Likely Benign
6
Benign
1
Conflicting

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
8
3
0
0
11
Likely Pathogenic
10
2
0
0
12
VUS
1
98
1
1
101
Likely Benign
0
3
7
46
56
Benign
0
1
4
1
6
Conflicting
1
Total191071248187

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

98 pathogenic / likely-pathogenic (of 118) ClinVar copy-number / structural variants overlap NKX6-2 — these span large chromosomal regions, not the gene specifically, and are excluded from the counts above. Explore in CNV tools →

Protein Context — Lollipop Plot

NKX6-2 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →